|
Stock picks by the pros
|
 |
December 4, 2000: 1:55 p.m. ET
Wells Fargo, Comverse, Genentech, Chubb, Scientific-Atlanta win mention
|
NEW YORK (CNNfn) - Market strategists reviewed stocks in the finance, biotech and communication equipment sectors, recommending companies such as Amgen.
As the markets were mixed in midday trading Monday, recent guests on CNNfn commented on the stocks they are buying and why.
| |
 MARSHALL ACUFF'S STOCK PICKS:
|
|
| |
|
CB
WFC
AMGN
DNA
|
|
|
"Quite frankly, as a sector, it's hard to beat the financials, but having said that, I think one still has to be selective, but in that area I find a lot of value. The casualty insurers, for example, like a Chubb (CB: Research, Estimates) certainly fit that. A Wells Fargo (WFC: Research, Estimates) certainly would be another example in the bank category," said Marshall Acuff, equity strategist at Citigroup/Salomon Smith Barney. "Biotech has held up very well. It's an area I've liked for a long time. I'm not new to it, but I think an Amgen (AMGN: Research, Estimates) or a Genentech (DNA: Research, Estimates), particularly for investors, is longer term. I think we're very early in what is increasing improvement of new product flow. Increasing productivity in the biotech sector."
Chubb is trading up $1.25 to $85.38 with a 52-week high of $87.56 and a 52-week low of $43.25.
Wells Fargo is trading down 72 cents to $46.66 with a 52-week high of $48.62 and a 52-week low of $31.37.
Amgen is trading up 38 cents to $65.19 with a 52-week high of $80.43 and a 52-week low of $42.62.
Genentech is trading down $1.50 to $70.25 with a 52-week high of $122.50 and a 52-week low of $40.56.
| |
PAUL MEEKS' STOCK PICKS:
|
|
| |
|
CMVT
SFA
TLAB
|
|
|
"We manage about $4 billion here. And I probably have throughout my six portfolios a weighted average cash position, that's pretty high, of about 15 percent. So, what I'm doing is I'm buying toe-hold positions on certain days, adding to existing positions I like. Introducing some new stocks and when I introduce a new stock, it's typically more of a value tech stock that I've been buying all year. A couple of stocks that fit that bill that bought recently, that have a nice valuation floor, plus some pretty good fundamentals, companies like Comverse (CMVT: Research, Estimates), Scientific-Atlanta (SFA: Research, Estimates), Tellabs (TLAB: Research, Estimates) are some names that if things get rough, they are showing a nice valuation basis," said Paul Meeks, portfolio manager of the Merrill Lynch Global Technology Fund.
Comverse is trading up $2.19 to $95.19 with a 52-week high of $123.57 and a 52-week low of $56.50.
Scientific-Atlanta is trading up $1 to $44.63 with a 52-week high of $94 and a 52-week low of $24.40.
Tellabs is trading up 69 cents to $60.19 with a 52-week high of $76.93 and a 52-week low of $37.62. 
-- compiled by Staff Writer Lucy Banduci
* Disclaimer
|
|
|
|
|
|
Track your stocks
|
Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney
|
|
|
|
 |
|
